512 related articles for article (PubMed ID: 9817026)
41. Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
Gao L; Sun H; Yao SQ
Biopolymers; 2010; 94(6):810-9. PubMed ID: 20725946
[TBL] [Abstract][Full Text] [Related]
42. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
43. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
44. [Protein tyrosine phosphatases--endogenous markers of oxidative stress].
Kuban-Jankowska A; Górska M; Debicki A; Popowska U; Knap N; Woźniak M
Postepy Biochem; 2010; 56(3):269-73. PubMed ID: 21117314
[TBL] [Abstract][Full Text] [Related]
45. High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.
Mattila E; Ivaska J
Anticancer Agents Med Chem; 2011 Jan; 11(1):141-50. PubMed ID: 21288196
[TBL] [Abstract][Full Text] [Related]
46. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo.
Meng TC; Hsu SF; Tonks NK
Methods; 2005 Jan; 35(1):28-36. PubMed ID: 15588983
[TBL] [Abstract][Full Text] [Related]
47. Bidentate inhibitors of protein tyrosine phosphatases.
Low JL; Chai CL; Yao SQ
Antioxid Redox Signal; 2014 May; 20(14):2225-50. PubMed ID: 24206395
[TBL] [Abstract][Full Text] [Related]
48. Protein tyrosine phosphatases in cancer: friends and foes!
Labbé DP; Hardy S; Tremblay ML
Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
[TBL] [Abstract][Full Text] [Related]
49. Covalent inhibition of protein tyrosine phosphatases.
Ruddraraju KV; Zhang ZY
Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
[TBL] [Abstract][Full Text] [Related]
50. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
He R; Zeng LF; He Y; Zhang S; Zhang ZY
FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
[TBL] [Abstract][Full Text] [Related]
51. Physiological signaling specificity by protein tyrosine phosphatases.
Soulsby M; Bennett AM
Physiology (Bethesda); 2009 Oct; 24():281-9. PubMed ID: 19815854
[TBL] [Abstract][Full Text] [Related]
52. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
Shen K; Qi L; Stiff L
Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
[TBL] [Abstract][Full Text] [Related]
53. PTP1B: from the sidelines to the front lines!
Tonks NK
FEBS Lett; 2003 Jul; 546(1):140-8. PubMed ID: 12829250
[TBL] [Abstract][Full Text] [Related]
54. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
Schmidt MF; Groves MR; Rademann J
Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
[TBL] [Abstract][Full Text] [Related]
55. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
Pulido R; Stoker AW; Hendriks WJ
Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
[TBL] [Abstract][Full Text] [Related]
56. Protein tyrosine kinases: structure, substrate specificity, and drug discovery.
al-Obeidi FA; Wu JJ; Lam KS
Biopolymers; 1998; 47(3):197-223. PubMed ID: 9817025
[TBL] [Abstract][Full Text] [Related]
57. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
58. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
Reddy RH; Kim H; Cha S; Lee B; Kim YJ
J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
[TBL] [Abstract][Full Text] [Related]
59. Mechanistic studies on protein tyrosine phosphatases.
Zhang ZY
Prog Nucleic Acid Res Mol Biol; 2003; 73():171-220. PubMed ID: 12882518
[TBL] [Abstract][Full Text] [Related]
60. Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.
Vidović D; Schürer SC
J Med Chem; 2009 Nov; 52(21):6649-59. PubMed ID: 19810703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
